We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Effectiveness of FDA's new over-the-counter acetaminophen warning label in improving consumer risk perception of liver damage.
- Authors
Goyal, R K; Rajan, S S; Essien, E J; Sansgiry, S S
- Abstract
The Food and Drug Administration (FDA) issued new organ-specific warning label requirements for over-the-counter (OTC) analgesic products in order to make consumers aware of the risk of liver damage when using acetaminophen. However, awareness of a health risk alone cannot ensure consumers' engagement in safe and preventive behaviour. In this study, we attempted to: (i) measure consumer risk perception of liver damage due to the OTC acetaminophen products and (ii) analyse the effectiveness of the new organ-specific warning label in improving consumer risk perception of liver damage and intention to perform protective behaviours while using OTC acetaminophen products.
- Publication
Journal of clinical pharmacy and therapeutics, 2012, Vol 37, Issue 6, p681
- ISSN
1365-2710
- Publication type
Journal Article
- DOI
10.1111/j.1365-2710.2012.01371.x